Novartis receives third FDA approval for oral Fabhalta® (iptacopan) – the first and only treatment approved in C3 glomerulopathy (C3G) Fabhalta is the only oral alternative complement pathway ...

The FDA is stepping up its oversight of infant formula, including increased testing for heavy metals and other contaminants. Here's what to know.

FDA priority review of pz-cel Biologics License Application (BLA) progressing with Prescription Drug User Fee Act (PDUFA) ...

Dermatologists are increasingly prescribing low-dose minoxidil pills for hair loss, finding them potentially more effective ...

FDA priority review of pz-cel Biologics License Application (BLA) progressing with Prescription Drug User Fee Act (PDUFA) target action date of April 29, 2025 Launch preparations on track toward goal ...

Toxics watchdog BAN Toxics has issued a warning to parents and children against buying toys inspired by the popular online ...

Pharmaceuticals generated fourth quarter 2024 net FUROSCIX® revenue of $12.2 million, and full year 2024 revenue of $36.3 million Cash and cash equivalents of $75.7 million as of December 31, 2024 ...

An NBC News analysis found hundreds of lawsuits over five years alleging that embryos were lost, destroyed or swapped by ...

On those days when the folks at Alabama Sunshine are making their XXX Black Label hot sauce, the fumes from those fiery red ...

The U.S. Food and Drug Administration on Thursday launched an online searchable database listing contaminant levels in human ...

In a win for some food industry groups, the Food and Drug Administration plans to extend the deadline for a major food safety ...